| dc.contributor.author | Alam, MI | en_US |
| dc.contributor.author | Coad, DS | en_US |
| dc.contributor.author | Bogacka, B | en_US |
| dc.date.accessioned | 2019-07-23T10:21:02Z | |
| dc.date.available | 2019-06-05 | en_US |
| dc.date.issued | 2019-09-20 | en_US |
| dc.identifier.issn | 0277-6715 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/58619 | |
| dc.format.extent | 4172 - 4188 | en_US |
| dc.relation.ispartof | STATISTICS IN MEDICINE | en_US |
| dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in Statistics in Medicine following peer review. The version of record is available https://onlinelibrary.wiley.com/doi/full/10.1002/sim.8292 | |
| dc.subject | adaptive design | en_US |
| dc.subject | continuation ratio model | en_US |
| dc.subject | D-optimum design | en_US |
| dc.subject | penalty function | en_US |
| dc.subject | phase I | en_US |
| dc.subject | II trial | en_US |
| dc.title | Combined criteria for dose optimisation in early phase clinical trials | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2019 John Wiley & Sons, Ltd. | |
| dc.identifier.doi | 10.1002/sim.8292 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000480285000016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 21 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 38 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
